EXPRESSION OF RECOMBINANT HUMAN CYTOCHROME P450 (P450 OR CYP) 2A6 IN ESCHERICHIA COLI.

スポンサーリンク

概要

• 論文の詳細を見る
• 日本トキシコロジー学会の論文
• 1998-05-09

著者

• Yokoi T

  Department Of Medicine And Clinical Science Gunma University Graduate School Of Medicine

• Yokoi Tsuyoshi

  北海道大学 薬研究 代謝分析

• Fujita K

  Graduate School Of Science Osaka City University

• Fujita Ken-ichi

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• Fujita Ken-ichi

  Lab.drug Metab. Grad.sch.pharm.sci. Hokkaido Univ.

• Fujita K

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• Kamataki T

  Hokkaido Univ. Sapporo Jpn

• Kamataki Tetsuya

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• FUJITA Ken-ichi

  Div, Drug Metab., Pharm.Sci., Hokkaido Univ.

• KUSHIDA Hirotaka

  Div, Drug Metab., Pharm.Sci., Hokkaido Univ.

• SAKUMA Tsutomu

  Div, Drug Metab., Pharm.Sci., Hokkaido Univ.

• NUNOYA Ken-ichi

  Div, Drug Metab., Pharm.Sci., Hokkaido Univ.

• YOKOI Tsuyoshi

  Div, Drug Metab., Pharm.Sci., Hokkaido Univ.

• ENDOU Tsutomu

  Central Res.Lab., Tsumura & Co.,

• KAMATAKI Tetsuya

  Div, Drug Metab., Pharm.Sci., Hokkaido Univ.

• Kushida Hirotaka

  Medicinal Evaluation Laboratory Tsumura & Co.

• Fujita Ken-ichi

  Div Drug Metab. Pharm.sci. Hokkaido Univ.

• Sakuma Tsutomu

  Div Drug Metab. Pharm.sci. Hokkaido Univ.

• Kamataki Tetsuya

  Lab.drug Metab. Grad.sch.pharm.sci. Hokkaido Univ.

• Tsumita Yuki

  Department Of Medicine And Clinical Science Gunma University Graduate School Of Medicine

• Endou Tsutomu

  Central Res.lab. Tsumura & Co.

• Yokoi Tsuyoshi

  Division Of Drug Metabolism And Toxicology Faculty Of Pharmaceutical Sciences Kanazawa University

• Yokoi Tsuyoshi

  Laboratory Of Drug Metabolism Division Of Pharmacobio-dynamics Graduate School Of Pharmaceutical Sci

• Yokoi T

  Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University

• Yokoi Tsuyoshi

  Fac.pharm. Sci. Hokkaido Univ.

• Kamataki Tetsuya

  Laboratory Of Drug Metabolism Division Of Pharmacobio-dynamics Graduate School Of Pharmaceutical Sci

• Yokoi Tsuyoshi

  Div.drug Metab. Fac.of Pharm.sic. Hokkaido Univ.

• Kamataki Tetsuya

  Div.drug Metab. Fac.of Pharm.sic. Hokkaido Univ.

• Kamataki Tetsuya

  Lab. Drug Metab. Fac. Pharm. Sci. Hokkaido University

• Kamataki Tetsuya

  Laboratory of Drug Metabolism, Hokkaido University Graduate School of Pharmaceutical Sciences

• Kushida Hirotaka

  Medicinal Evaluation Laboratory, Tsumura & Co.

関連論文

• MACROMOLECULAR BINDING OF CARCINOGENIC/MUTAGENIC N- HYDROXYARYLAMINES THROUGH O-ACETYLATION PATHWAY
• MECHANISM OF MUTATION AND METABOLIC ACTIVATION OF NITRO-, NITROSO-, HYDROXYLAMINO-COMPOUNDS IN NITRO-COMPOUNDS RESISTANT MUTANTS OF AMES TESTAR STRAIN (TA98NR, TA98/1,8-DNP_6)
• Two Novel Single Nucleotide Polymorphisms (SNPs) of the FMO3 Gene in Japanese
• A Mutation in the Flavin-containing Monooxygenase 3 Gene and its Effects on Catalytic Activity for N-oxidation of Trimethylamine In Vitro
• The influence of the sennosides on absorption of glycyrrhetic acid in rats
• Overexpression of CYP2A6 in human colorectal tumors
• O11-01 Induction of Human CYP1A1 by 2-Phenyl-benzotriazoles(PBTAs)which Are Metabolically Activated by CYP1A1
• O-18 Role of Human N-Acetyltransferase in the Metabolic Activation of 2-Phenylbenzotriazole (PBTA) Derivatives.(Proceedings of the 27th Annual Meeting)
• 21C-01-1 Metabolic Activation of PBTA-1 and PBTA-2 by Human Cytochrome P450 1A1.
• Cytochrome P450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver
• Establishment of in silico systems to predict the effects of genetic polymorphism on the enzymatic activity of cytochrome P450
• ROLE OF GROWTH HORMONE ON THE EXPRESSION OF SEX-SPECIFIC FORMS OF CYTOCHROME P-450,P-450-MALE AND P-450-FEMALE
• STUDIES ON SEX-SPECIFIC FORMS OF CYTOCHROME P-450 IN MALE AND FEMALE RATS
• Inhibitory Effects of Nicardipine to Cytochrome P450 (CYP) in Human Liver Microsomes(Biopharmacy)
• Co-operative Regulation of the Transcription of Human Dihydrodiol Dehydrogenase(DD)4/Aldo-Keot Reductase(AKR)1C4 Gene by Hepatocyte Nuclear Factor(HNF)-4α/γand HNF-1α.
• Characterization of a Novel Variant (S145C/L311V) of 3α-Hydroxysteroid/Dihydrodiol Dehydrogenase in Human Liver.
• CHARACTERIZATION OF TRANSGENIC MICE CARRYING A HUMAN FETUS-SPECIFIC CYP3A7.
• Inhibiton by EGCG of benzo[a]pyrene-induced mutations in the lung of HITEC mice.
• CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers.(GENERAL SESSION BY ORAL PRESENTATION)(DRUG METABOLISM)
• 2B-08 Establishment of Genetically Engineered E.coli Highly Sensitive to Nitrosamines by Introducing Human CYP2E1
• Twenty One Novel Single Nucleotide Polymorphisms (SNPs) of the CYP2A6 Gene in Japanese and Caucasians
• CYP3A5 Contributes Significantly to CYP3A-mediated Drug Oxidations in Liver Microsomes from Japanese Subjects
• Isolation of an Acremonium sp. Capable of Liquefying Cross-Linked Poly(γ-Glutamic Acid) Hydrogels and the Fungal Enzyme Involved in the Disruption of γ-Ray Irradiation-Mediated Cross-Linking(MISCELLANEOUS)
• Flocculating Activity of Cross-linked Poly-γ-Glutamic Acid against Bentonite and Escherichia coli Suspension Pretreated with FeCl_3 and Its Interaction with Fe^(ENVIRONMENTAL BIOTECHNOLOGY)
• TOXICOLOGICAL SIGNIFICANCE OF A FORM OF CYTOCHROME P-450 HIGHLY PURIFIED FROM LIVER MICROSOMES OF PCBTREATED RATS : CATALYTIC AND IMMUNOCHEMICAL EXAMINATIONS OF A HIGH SPIN FORM OF CYTOCHROME P-448
• Application of Primary Hepatocytes from p53-Knockout Mice for Studies of Expression of Cyp3a
• Expression of human CYP1A2 capable of activating heterocyclic amine in Bm 6 cells using baculovirus (BmNPV) system.
• In vivo Evaluation of Coumarin and Nicotine as Probe Drugs to Predict the Metabolic Capacity of CYP2A6 Due to Genetic Polymorphism in Thais
• Novel Nonsynonymous Polymorphisms of the CYP1A1 Gene in Japanese
• Toxicological roles of human and rodent CYP2As in the mutagenic activation of N-nitrosamines.(GENERAL SESSION BY ORAL PRESENTATION)(DRUG METABOLISM)
• Novel Mutations of the CYP2A6 Gene in a Thai Population with Lowered Capacity of Coumarin 7-Hydroxylation
• O11-15 Mutagenic activation of tobacco-related N-nitrosamines by rat CYP2As in comparison with human CYP2A6.
• O11-14 Comparison of the toxicolqical roles of mouse CYP2A with human CYP2A6.
• Genetic Polymorphism in the 5'-Flanking Region of Human CYP1A2 Gene : Effect on the CYP1A2 Inducibility in Humans
• Two Novel Haplotypes of CYP2D6 Gene in a Japanese Population
• Eighteen Novel Polymorphisms of the CYP2A13 Gene in Japanesse
• METABOLIC ACTIVATION OF AFLATOXIN B_1 BY HUMAN PLACENTAL MICROSOMES
• Formation of an Antibacterial Metabolite from a New Macrolide Compound 23-O-Benzyl-5-mycaminosyl-tylonolide (TMC-101), by a Hepatic Microsomal Drug-Metabolizing Enzyme System
• 5-2) MOLECULAR TOXICOLOGY ON CYTOCHROME P-450 IN HUMAN FETAL LIVERS
• Immunochemical Studies for the Presence of P-450 HFLa, a Form of Cytochrome P-450 in Human Fetal Livers in Human Hepatocellular Carcinoma Cells
• SPECIES DIFFERENCE OF CYTOCHROME (S) P-450 CROSS-REACTIVE WITH ANTI-P-450-MALE ANTIBODIES
• Large-scale Production of Genetically Engineered CYP3A4 in E. coli: Application of a Jarfermenter
• 21C-04-1 Inhibition of the Activity of Human Cytochrome P450 Involved in the Metabolic Activation of Procarcinogens by Green Tea Catechins.
• Establishment of Salmonella Tester Strains Co-expressing Cytochrome P450 and NADPH-cytochrome P450 Reductase.
• Application of Genetically Engineered Bacteria Carrying Human Cytochrome P450 to Toxicological Studies
• Metabolic Activation of Dimethylnitrosamine(DMN) by Human CYP2E1 Expressed in O^6-Methylguanine-DNA Methyltransferase-Deficient Cells
• Establishment Of A Salmonella Tester Strain Ultra-Sensitive To Mutagenic Heterocyclic Amines
• DEVELOPMENT OF PRACTICAL METHODS WHICH MIMIC DRUG METABOLISM IN HUMANS.
• EXPRESSION OF RECOMBINANT HUMAN CYTOCHROME P450 (P450 OR CYP) 2A6 IN ESCHERICHIA COLI.
• "S2-3 STRATEGIC PROPOSALS TO AVOID TOXIC DRUG INTERACTIONS DURING NEW DRUG DEVELOPMENT : MOLECULAR TOXICOLOGY PROPOSALS (Strategy how we can learn drug-drug interaction during the development of a new drug)
• Stable expression of CYP3A4 and CYP3A7, adult and fetal-specific forms of cytochrome P450 in human liver, in CHL cells and its application to toxicological testing.
• Effects of NO-1886 (Ibrolipim), a Lipoprotein Lipase-Promoting Agent, on Gene Induction of Cytochrome P450s, Carboxylesterases, and Sulfotransferases in Primary Cultures of Human Hepatocytes
• Detection of Three Genetic Polymorphisms in the 5'-Flanking Region and Intron 1 of Human CYP1A2 in the Japanese Population
• Homologous Unequal Cross-Over within the Human CYP2A Gene Cluster as a Mechanism for the Deletion of the Entire CYP2A6 Gene Associated with the Poor Metabolizer Phenotype
• Thiopurine Methyltransferase Genotype and Phenotype Status in Japanese Patients with Systemic Lupus Erythematosus(Biopharmacy)
• Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients
• Sulfite is Generated from PAPS by Activated Neutrophils
• Extremely high levels of C-reactive protein in patients with acute lupus serositis
• 221 INTRODUCTION OF CYTOCHROME P-450 cDNAS INTO CULTURED MAMMALIAN CELLS AND THEIR APPLICATION TO IN VITRO TOXICOLOGICAL STUDIES
• Identification of Phoslactomycin E as a Metabolite Inducing Hyphal Morphological Abnormalities in Aspergillus fumigatus IFO 5840
• Amplification of Vacuole-targeting Fungicidal Activity of Antibacterial Antibiotic Polymyxin B by Allicin, an Allyl Sulfur Compound from Garlic
• Synergistic Fungicidal Activities of Amphotericin B and N-Methyl-N"-dodecylguanidine : A Constituent of Polyol Macrolide Antibiotic Niphimycin
• Inhibitory Activity of 1-Farnesylpyridinium on the Spatial Control over the Assembly of Cell Wall Polysaccharides in Schizosaccharomyces pombe
• P-502 Structure-Activity Relationship Studies on UK-2A, A Novel Antifungal Antibiotic from Streptomyces sp. 517-02
• P-368 Identification of Phoslactomycin E as a Metabolite Inducing Hyphal Morphological Abnormalities of Aspergillus fumigatus IFO 5840
• Involvement of Oxidative Stress Induction in Na^+ Toxicity and Its Relation to the Inhibition of a Ca^-Dependent but Calcineurin-Independent Mechanism in Saccharomyces cerevisiae(MICROBIAL PHYSIOLOGY AND BIOTECHNOLOGY)
• Biosynthesis of Poly-γ-Glutamic Acid in Plants : Transient Expression of Poly-γ-Glutamate Synthetase Complex in Tobacco Leaves(PLANT BIOTECHNOLOGY)
• Proposals for Wastewater Treatment by Applying Flocculating Activity of Cross-linked Poly-γ-Glutamic Acid(Environmental Biotechnology)
• Physicochemical Properties of Cross-linked Poly-γ-Glutamic Acid and Its Flocculating Activity against Kaolin Suspension (Environmental Biotechnology)
• Oxidative Stress-Dependent Inhibition of Yeast Cell Growth by Farnesylamine and Its Possible Relation to Amine Oxidase in the Mitochondrial Fraction(MICROBIAL PHYSIOLOGY AND BIOTECHNOLOGY)
• UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 : VI (3). Role of Substituents on Dilactone Ring of UK-2A and Antimycin A_3 against Generation of Reactive Oxygen Species in Porcine Renal Proximal Tubule LLC-PK_1 Cells
• Growth Inhibition Dependent on Reactive Oxygen Species Generated by C9-UK-2A, a Derivative of the Antifungal Antibiotic UK-2A, in Saccharomyces cerevisiae
• UK-2A,B,C, and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 VIII. Reactive Oxygen Species Generated by C9-UK-2A, a Derivative of UK-2A, in Rhodotorula mucilaginosa IFO 0001
• UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 VI.(2). Structure-activity Relationships of UK-2A
• UK-2A, B, C, and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 : VII. Membrane Injury Induced by C9-UK-2A, a Derivative of UK-2A, in Rhodotorula mucilaginosa IFO 0001
• L-2,5-Dihydrophenylalanine, an Inducer of Cathepsin-dependent Apoptosis in Human Promyelocytic Leukemia Cells(HL-60)
• Antifungal Activity of Radicicol against Mucor flavus IFO 9560
• Studies on the Interactions between Drug and Estrogen. II. On the Inhibitory Effect of 29 Drugs Reported to Induce Gynecomastia on the Oxidation of Estradiol at C-2 or C-17
• Role of cyclosporin A in remitting nephrotic syndrome in a Japanese patient infected with human immunodeficiency virus type 1
• Acute Myeloid Leukemia Accompanied by Multiple Thrombophlebitis
• Preventive Effects of Hange-shashin-to on Irinotecan Hydrochloride-Caused Diarrhea and Its Relevance to the Colonic Prostaglandin E_2 and Water Absorption in the Rat
• Production of Inhibitory Polyclonal Antibodies against Cytochrome P450s
• Separation of microsomal cytochrome b_5 via phase separation in a mixed solution of Triton X-114 and charged dextran
• Selective Solubilization of Microsomal Electron-Transfer Proteins with Alkylglucoside
• Metabolism of Selegiline Hydrochloride, a Selective Monoamine B-type Inhibitor, in Human Liver Microsomes
• UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 VI(1). Structure-Activity Relationship of UK-2A
• OCCURRENCE OF AUTOANTIBODY TO PROTEIN DISULFIDE ISOMERASE IN PATIENTS WITH HEPATIC DISORDER
• OCCURRENCE OF AUTOANTIBODY TO PROTEIN DISULFIDE ISOMERASE IN RATS WITH XENOBIOTIC-INDUCED HEPATITIS
• Relevance of Irinotecan Hydrochloride-Induced Diarrhea to the Level of Prostaglandin E_2 and Water Absorption of Large Intestine in Rats
• Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient
• MOLECULAR CLONING OF MOUSE LIVER FLAVIN CONTAINING MONOOXYGENASE (FMO1) cDNA AND CHARACTERIZATION OF THE EXPRESSION PRODUCT : METABOLISM OF THE NEUROTOXIN, 1,2,3,4- TETRAHYDROISOQUINOLINE (TIQ)
• High-performance liquid chromatographic assay with fluorescence detection for the determination of cephaeline and emetine in human plasma and urine
• Induction of Human CYP1A2 and CYP3A4 in Primary Culture of Hepatocytes from Chimeric Mice with Humanized Liver
• HIGH SUSCEPTIBILITY TO AFLATOXIN B_1 AND BENZO[A]PYRENE OF BALB3T3 A31-1-1 CELLS EXPRESSING MONKEY CYP1A1
• FUNCTIONAL CO-EXPRESSION OF HUMAN CYTOCHROME P450 (CYP) 2A6 with NADPH-P450 REDUCTASE IN SALMONELLA TYPHMIURIUM YG7108.
• Evaluation of Human CYP1A2 and CYP3A4 mRNA Expression in Hepatocytes from Chimeric Mice with Humanized Liver
• A Major Genotype in UDP-glucuronosyltransferase 2B15
• Cell-specific transcriptional regulation of the human CYP1B1 (DRUG METABOLISM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies
• Lung tumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotine metabolite through activation of PI3K/Akt pathway

もっと見る 閉じる

スポンサーリンク